Last Updated on 2 years by Publishing Team

COVID-19 Situation Update

Friday 04th March

Transmission Update:

Since the last update, we have recorded 15 new cases of which 3 new cases were recorded on 03/03/2022 and 12 new cases in the last 24 hours ending at 8 am this morning.

Of the 15 cases recorded, 6 cases were recorded in the Central Division; 6 cases were recorded in the Western Division, 3 cases were recorded in the Northern Division, and nil case was recorded in the Eastern Division.

Overall, there have been 63,949 cases of COVID-19 recorded in Fiji, with 68% of the cases from the Central Division, 27% of the cases from the Western Division, 2% of the cases from the Eastern Division, and 3% from the Northern Division.

The national 7-day rolling average of cases as of 28th February is 45 daily cases.


The curves depict daily COVID-19 deaths by division since May 2021. It indicates a surge from December-end 2021, which peaks by mid-January 2022. The 3rd COVID 19 wave is considered to have started around mid to late December 2021. (Note: Death notifications from within the last two weeks are still being received, therefore the graphs may alter slightly upon reporting).

Analysis of Deaths in the Third Wave 

Table 1: Death rates by Division

Division Total COVID Deaths Deaths per 100,000
Central 61 15.2
Western 44 12.3
Northern 28 20.0
Eastern 5 13.0

An analysis of the 138 deaths recorded in the third wave show that, while the Central Division has the highest absolute number of deaths, the Northern Division has the highest rate of death when adjusted for population

Table 2: Deaths by Age Group

Age Group Total Deaths Deaths per 100,000 population
0 – 9 6 3.3
10-19 2 1.3
20-29 3 2.1
30-39 4 2.9
40-49 6 5.8
50-59 18 19.8
60-69 27 51.9
70-79 42 187.5
80-89 23 408.8
90-99 5 961.5

For the 138 deaths in the third wave, the death rate adjusted per 100,000 population, has been highest in age groups 50 and onwards. There were 8 deaths below the age of 19 years, 7 out of the 8 children had significant pre-existing medical conditions, and one child had no known underlying medical condition.

Table 3: Deaths by Vaccination Status

Age Cohort Total COVID deaths Total Vaccinated/ Unvaccinated Deaths per 100,000 Vaccinated Population Deaths per 100,000 Unvaccinated Population
>18 130 55/75 9.5 175.1
15-17 1 0/1 0 6.6
12-14 1 0/1 0 2.5

Out of 138 COVID -19 deaths reported in the third wave, six (6) deaths were in the population not eligible for vaccination (under age 12). An analysis of the 132 deaths in the vaccine-eligible population reflected, that when adjusted per 100,000 population, for fully vaccinated (received 2 doses) and unvaccinated/not fully vaccinated (received 0 doses or only 1 dose) adults in Fiji, a death rate of 9.5 per 100,000 population for fully vaccinated adults and 176.3 for unvaccinated adults was exhibited. This means that unvaccinated adults in Fiji have been dying at a rate 18.5 times higher than fully vaccinated adults during the current COVID-19 wave. Individuals of the 12-17 age group who died were not vaccinated. There have been no COVID-19 deaths in individuals who received a booster (3rd dose) of the vaccine.

New deaths to report

There are no new COVID-19 deaths to report.

There have been a total of 834 deaths due to COVID-19 in Fiji. Please note that due to the time required by clinical teams to investigate, classify and report deaths, a 4-day interval is given to calculate the 7 days rolling average of deaths, based on the date of death, to help ensure the data collected is complete before the average is reported. Therefore, as of February 28th, 2022, the national 7 days rolling average for COVID-19 deaths per day is 0.1, with a case fatality rate of 1.29%.

We have recorded 903 COVID-19 positive patients who died from other serious medical conditions unrelated to COVID-19; their doctors determined that COVID-19 did not contribute to their deaths, therefore these are not classified as COVID-19 deaths.


There is a sustained downward trend in daily hospitalizations. Using the WHO clinical severity classification, a greater percentage, 78% (n=7) of the admissions of COVID-19 positive patients are categorised as asymptomatic and mild, 11% (n=1) is categorised as moderate and 11% (n=1) as severe with nil cases in the critical category. Anyone admitted to the hospital is tested before admission, therefore, a significant number of people are admitted to the hospital for non-covid health conditions, but incidentally, test positive due to the high amount of transmission in the community. The number of people being admitted because of COVID-19 remains low.


139 tests have been reported for March 3rd, 2022. Total cumulative tests since 2020 are 497,869 tests. The 7-day daily test average is 177 tests per day or 0.2 tests per 1,000 population.

The national 7-day average daily test positivity is 10.9%. The high positivity rate is an indication of widespread community transmission.

Public Advisory:

Leptospirosis, typhoid fever, and dengue fever

As previously mentioned, the recent weather has resulted in conditions conducive to outbreaks of leptospirosis, typhoid, and dengue fever, which are climate-sensitive diseases endemic to Fiji. We are also aware of the recent weather reports predicting increasing rainfall over the next few days, and as such the medical advice we provide needs to be followed, while we continue to mount our public health and clinical response. We have especially noted increasing leptospirosis cases, hospitalisations, and deaths following similar weather events. Please heed our advice to protect yourselves and your loved ones.


The Permanent Secretary of Health together with senior advisory managers are currently visiting the Ra sub-division to speculate on the current rising cases of leptospirosis in the division.

Being an infectious disease, there have been 567 confirmed cases of leptospirosis in Fiji so far, with outbreaks occurring in all four divisions.

An increase in the number of cases admitted to hospitals infected with leptospirosis has been noted, with a death toll of 23 since the last update on 23/02/2022.

Although all age groups are able to host the infection, cases remain predominantly higher in ages 10-39-years more in males than females, and in people of the i-Taukei ethnicity.


The leptospirosis bacteria is spread to humans through the urine of infected animals, such as cows, pigs, rats, and dogs. To reduce your individual risk, it is important to understand that exposure to animals, soil, mud, and floodwaters during work or recreational activities increases your risk of infection.

Important prevention measures include wearing full covered footwear at all times when going outdoors, avoiding wading or swimming in flooded waters, using clean fresh water to wash up after exposure to muddy waters, and keeping all food and drinks covered and away from rats. For workplaces, practice good personal hygiene at all times, cover cuts and wounds well, and use protective equipment, especially footwear when in flooded and/or muddy areas.

We are also urging all parents and guardians to prevent children from playing in the mud or swimming in flooded rivers or creeks, and ensure that they wear shoes when outside.

Symptoms and treatment

Early treatment can decrease the severity and duration of the disease. Please seek medical care if you have recently had contact with floodwaters, mud, or animals, and develop the following symptoms: fever, muscle pain, headache. You may also have red eyes, loss of appetite, nausea/vomiting, dizziness, or feel weak.

Leptospirosis can be treated with appropriate antibiotic medications prescribed by a doctor if treatment is sought early. Danger signs for severe leptospirosis include shortness of breath, coughing blood, chest pain, yellow eyes/skin (jaundice), signs of bleeding (including unexplained bruising), decreased or increased urination, difficulty staying awake. Severe leptospirosis is life-threatening, and anyone with these symptoms must be taken to the hospital immediately.


In response to the leptospirosis outbreak, the Ministry has mobilized FEMAT, first to Navosa, and now to Ra to assist the local medical teams in providing services and outreach to communities. Awareness messaging has also been distributed to the public through radio, television, print, and social media, focusing on prevention and early healthcare seeking for suspected cases. And our clinicians have had access to continuing medical education sessions remotely, or in person, by our specialist physicians from the divisional hospitals, to promote early diagnosis and treatment of people who may have leptospirosis.

Typhoid fever

There have been 44 cases of typhoid fever in Fiji this year. This is equivalent to the number recorded within the same time period last year.

Typhoid fever is typically found in areas that do not have access to clean drinking water. We strongly encourage people who live in rural areas, informal urban areas, and any other areas where access to clean drinking water is limited, to boil all drinking water. We must all also continue to practise basic hygiene measures such as frequently washing hands with soap and water, especially after visiting the toilet and before eating or preparing food.

Dengue fever

There have been 633 confirmed cases of dengue fever in Fiji so far, which is within the numbers expected for this time of the year.

We continue to urge everyone to get rid of potential mosquito breeding places, such as empty containers inside and outside your homes that may collect water, including discarded tires, flower vases, and pot plant bases. Protect yourself from being bitten by mosquitoes by using mosquito screens in your homes, and mosquito repellants.

COVID-19 Vaccination

As of the 04th of March, a total of 105,295 individuals have so far received booster doses. Members of the public are advised to obtain their booster dose after at least 5 months from their second COVID-19 vaccine dose. Moderna vaccine and Pfizer vaccines are both available for adult booster doses.

The Ministry of Health and Medical Services will continue to monitor the advisories on post-infection immunity based on quality data that is being generated globally

Given the current stocks of Pfizer Vaccine we have we will be using Pfizer for ongoing primary 2 dose schedule of children and adults and as the booster dose.

Supporting International Travel

  • Plan to remove 3-day hotel stay for fully vaccinated travellers from Travel Partner Countries.

Since the opening of international travel borders to travel partner countries travellers coming in from Travel Partner Countries have had to undergo an in-country test in Fiji on day 2 of stay in Fiji. To support this requirement, a 3-day hotel stay was mandated to minimize the risk of non-compliance to testing and to ensure that all positive tests were appropriately responded to while the traveller was locatable. To be clear, this 3-day stay in a Care Fiji Commitment (CFC) hotel was never a quarantine. The hotel stay is in place to facilitate the testing requirement on day 2 of arrival.

We have noted that while many countries have removed all forms of traveller sequestration, the in-country testing conditions continue. As such we are supporting current efforts to have more testing sites throughout Fiji to which travellers can book for testing, without requiring a hotel stay, as part of prior approval to come into Fiji. We are working together with the Ministry of Trade and Tourism and Ministry of Economy in the final phase of approving this in-country testing for international arrivals by private entities. These private entities will ensure that the test is available and the results will be reported back to Ministry of Health officials. They will also be mandated to report any international traveller who defaults from the mandatory testing. Any traveller defaulting a test will be subject to legal punitive measures.

  • Ongoing Review of Non-Travel Partner Country Status

This ongoing effort is mediated through the Ministry of Commerce, Trade, Tourism and Transport, and the Ministry of Economy (COVID-19 Risk Mitigation Taskforce). Non-Travel Partner Status is assessed and graduated to Travel Partner status based on COVID-19 Transmission Data (cases, admission, and deaths), COVID-19 Community Surveillance data (Test per 1000, positivity rate), and ability to detect Variants (Access to genomic sequence capability). A list of Travel partner countries is available on the following link:

Explore More

Measles Media Release no. 11

December 3, 2019 0 Comments 0 tags

0 Since the last update on November 28th 2019 there are now 15 confirmed cases of measles. The latest confirmed case is a 38 year old from Nasilai Village in

Ministry of Health Addresses COVID-19 JN.1 Sub-variant and Reinforces Protective Measures

January 5, 2024 0 Comments 0 tags

PR 02/2024  Ministry of Health Addresses COVID-19 JN.1 Sub-variant and Reinforces Protective Measures January 5th, 2024 The Ministry of Health & Medical Services (MHMS) in collaboration with the World Health

MoHMS current vacancies

April 25, 2016 0 Comments 0 tags

For a list of current vacancies (as of 26/04/16), please click here: Ministry of Health Vacancies